Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
Top Cited Papers
- 1 March 2007
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 8 (3), 226-234
- https://doi.org/10.1016/s1470-2045(07)70039-6
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Neoadjuvant chemoradiotherapy for esophageal carcinoma: A meta-analysisSurgery, 2005
- Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysisGut, 2004
- A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinomaAnnals of Oncology, 2004
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002
- Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trialThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 TrialJNCI Journal of the National Cancer Institute, 1996
- Combined modality therapy for esophageal carcinoma: Preliminary results from a large Australasian multicenter studyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Induction chemotherapy in the treatment of patients with carcinoma of the esophagusJournal of Surgical Oncology, 1994
- Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancerWorld Journal of Surgery, 1992
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985